Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Alzheimer'S Research & Therapy|October 10, 2022
Serum phosphorylated tau protein 181 and neurofilament light chain in cognitively impaired heart failure patientsJan Traub, Markus Otto, Roxane Sell, et al.
Annals of Clinical and Translational Neurology|August 9, 2023
High diagnostic performance of plasma and cerebrospinal fluid beta-synuclein for sporadic Creutzfeldt-Jakob diseaseSamir Abu-Rumeileh, Steffen Halbgebauer, Giuseppe Mario Bentivenga, et al.
Alzheimer'S Research & Therapy|November 24, 2022
Visinin-like protein 1 levels in blood and CSF as emerging markers for Alzheimer's and other neurodegenerative diseasesSteffen Halbgebauer, Petra Steinacker, Daniel Riedel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 2, 2020
Cerebrospinal Fluid Levels of Prodynorphin-Derived Peptides are Decreased in Huntington's DiseaseMhd Rami Al Shweiki, Patrick Oeckl, Adrian Pachollek, et al.
International Journal of Molecular Sciences|February 26, 2022
Prodynorphin and Proenkephalin in Cerebrospinal Fluid of Sporadic Creutzfeldt-Jakob DiseaseSamir Abu-Rumeileh, Peggy Barschke, Patrick Oeckl, et al.
Cell Death Discovery|March 13, 2025
TBK1 is involved in programmed cell death and ALS-related pathways in novel zebrafish modelsQuentin Raas, Gregoire Haouy, Hortense de Calbiac, et al.
Brain and Behavior|March 31, 2026
Association of Blood-Based Biomarkers and Malignant Infarction in Severe Anterior Circulation Ischemic StrokeDominik Lehrieder, Hermann Neugebauer, Alexander M Kollikowski, et al.
Alzheimer'S Research & Therapy|January 2, 2020
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementiaSamir Abu-Rumeileh, Petra Steinacker, Barbara Polischi, et al.
Scientific Reports|May 18, 2016
Modified serpinA1 as risk marker for Parkinson's disease dementia: Analysis of baseline dataSteffen Halbgebauer, Magdalena Nagl, Hans Klafki, et al.
Pageof 12